Young Adult Infusion Space Experience Satisfaction Survey

Cancer Clinical Trial

Official title:

Young Adult Infusion Space Survey: Comparing Experiences of Adolescents and Young Adults in Infusion Spaces at North Carolina Basnight Cancer Hospital

Clinical Trial Details — Status: Recruiting

Administrative data

• NCT number: NCT05720546
• Other study ID #: LCCC2228
• Status: Recruiting
• Start date: February 20, 2023
• Est. completion date: August 31, 2025

Study information

• Verified date: March 2024
• Source: UNC Lineberger Comprehensive Cancer Center
• Contact: Daniel Kleissler
• Phone: 919-928-6231
• Email: daniel_kleissler[@]med.unc.edu
• Is FDA regulated: No
• Study type: Observational

Clinical Trial Summary

The purpose of this study is to compare the satisfaction of Adolescent and Young Adults (AYA) receiving treatment in two different infusion spaces at the North Carolina Basnight Cancer Hospital (NCBCH). A survey and semi-structured interviews will be administered to participants to compare the experience with the built environment, with mental health staff, and between outpatient infusion spaces at NCBCH.

Recruitment information / eligibility

• Status: Recruiting
• Enrollment: 100
• Est. completion date: August 31, 2025
• Est. primary completion date: August 31, 2025
• Gender: All
• Age group: 18 Years to 39 Years

Eligibility

Inclusion Criteria:

1. Written informed consent obtained to participate in the study and HIPAA authorization for the release of personal health information.

2. Subjects are willing and able to comply with study procedures based on the judgment of the investigator or protocol designee.

3. Age 18-39 years old at enrollment.

4. Receiving treatment for a cancer diagnosis in Adult Infusion Center or the Adolescent and Young Adult Infusion Center

5. English speaking.

Exclusion Criteria:

1. Dementia, altered mental status, or any psychiatric condition as determined by the clinical or study team that would prohibit the understanding or rendering of informed consent.

2. Current incarceration.

Related Conditions & MeSH terms

• Cancer

Intervention

Other:
• Baseline Survey
A survey that measures participant satisfaction will be offered to participants during infusion at baseline.
• Semi-structured interviews
Semi-structured interviews will be conducted in the same infusion spaces.
• Follow-up Survey
A survey that measures participant satisfaction will be offered to participants during following infusion.

Locations

Country	Name	City	State
United States	UNC Lineberger Comprehensive Cancer Center	Chapel Hill	North Carolina

Sponsors (1)

Lead Sponsor	Collaborator
UNC Lineberger Comprehensive Cancer Center

Country where clinical trial is conducted

United States, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	General satisfaction	General satisfaction will be measured with participants' responses to satisfaction surveys that will be administered in specific infusion spaces.; Responses are rated on a Likert scale from 0 to 4. Scores will be summarized using frequency tables and percentages.	Baseline (up to 1 month)
Secondary	Satisfaction with the built environment	Subject satisfaction with the built environment will be measured with a survey item specific to the built environment administered in specific infusion spaces. The result of satisfaction in different infusion sites will be compared.; Responses are rated on a Likert scale from 0 to 2. Scores will be summarized using frequency tables and percentages.	Baseline (up to 1 month)
Secondary	Satisfaction with staff interaction	Subject satisfaction with staff interaction will be measured with a survey item specific to staff interactions administered in specific infusion spaces. The result of satisfaction in different infusion sites will be compared.; Responses are rated on a Likert scale from 0 to 4. Scores will be summarized using frequency tables and percentages.	Baseline (up to 1 month)
Secondary	Satisfaction with mental health	Subject satisfaction with mental health will be measured with survey items regarding emotional support and comfort administered in specific infusion spaces. The result of satisfaction in different infusion sites will be compared.; Responses are rated on a Likert scale from 0 to 4. Scores will be summarized using frequency tables and percentages.	Baseline (up to 1 month)

External Links

•   University of North Carolina Lineberger Comprehensive Cancer Center Clinical Trials